Treatment of Paraphimosis
Surgical Management
- The American Urological Association indicates that surgical intervention is necessary for cases where manual reduction techniques fail, or in severe cases with significant swelling or prolonged duration 1
- Surgical options include a dorsal slit procedure to relieve constriction, followed by elective circumcision after resolution of inflammation, as recommended by the American Urological Association 1
Prevention of Recurrence
- The American Academy of Pediatrics suggests that patients with recurrent episodes or underlying phimosis may benefit from topical steroid therapy, such as betamethasone 0.05% ointment applied twice daily for 4-6 weeks 2
- Elective circumcision may be considered for definitive management of recurrent paraphimosis, according to the American Urological Association 1
Special Considerations
- Patients with underlying lichen sclerosus have a higher likelihood of requiring surgical intervention, as noted by the American Urological Association 2
- The American Academy of Pediatrics recommends considering penile piercing as a possible cause of paraphimosis in young adults 3
Management and Treatment of Paraphimosis
Initial Assessment and Immediate Management
- Paraphimosis is a urologic emergency requiring immediate manual reduction, and if this fails, surgical intervention with a dorsal slit procedure is necessary to prevent glans necrosis, according to the European Urology guidelines 4
- This condition is classified as an emergency surgical condition in pediatric urology that should not be postponed, even during pandemic conditions, as stated by the European Urology guidelines 4
Special Populations and Considerations
- Patients with underlying lichen sclerosus have a higher likelihood of requiring surgical intervention and may be less responsive to conservative measures, and if circumcision is performed, topical corticosteroids should be continued postoperatively to prevent Koebnerization and further scarring, as recommended by the British Journal of Dermatology guidelines 5